Common Contracts
4 similar Securities Purchase Agreement contracts by Arena Pharmaceuticals Inc, Alimera Sciences Inc
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 28th, 2014 • Alimera Sciences Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 26, 2014, is by and among Alimera Sciences, Inc. (the “Company”) and Deerfield Private Design Fund II, L.P., Deerfield Private Design International II, L.P., Deerfield Private Design Fund III, L.P., Deerfield Special Situations Fund, L.P. and Deerfield Special Situations Fund International Master Fund, L.P. (collectively the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 11th, 2012 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 10, 2012, is by and among Arena Pharmaceuticals, Inc. (the “Company”) and Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P., Deerfield Partners, L.P., Deerfield International Limited, Deerfield Special Situations Fund, L.P. and Deerfield Special Situations Fund International Limited (collectively the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 29th, 2011 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 28, 2011, is by and among Arena Pharmaceuticals, Inc. (the “Company”) and Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P., Deerfield Partners, L.P., Deerfield International Limited, Deerfield Special Situations Fund, L.P. and Deerfield Special Situations Fund International Limited (collectively the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 6th, 2010 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of August 5, 2010, is by and among Arena Pharmaceuticals, Inc. (the “Company”) and Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P., Deerfield Partners, L.P., Deerfield International Limited, Deerfield Special Situations Fund, L.P. and Deerfield Special Situations Fund International Limited (collectively the “Investors”).
